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ABSTRACT
The truncation of the nonstructural NS1 protein is a novel approach for the generation of immunogenic attenuated influenza 
viruses. However, the innate immune mechanisms that cause the increased immunogenicity of influenza viruses with altered NS1 
proteins are poorly understood. The goal of this study was to compare the immune responses in mice immunized with two vari-
ants of the influenza A/Puerto Rico/8/1934 (A/PR8) virus: the wild type virus (А/PR8/full NS) and the variant with the NS1 protein 
shortened to 124 amino acid residues (А/PR8/NS124). The investigated parameters of immunity included cytokine production, 
the dynamic variation of the innate immune cell populations, and the rate of the influenza-specific T-cell responses. An intra-
peritoneal route of immunization was chosen due to the variability in the replication capacity of the investigated viruses in the 
respiratory tract. The levels of interferon β (IFNβ), tumor necrosis factor α (TNFα), monocyte chemo-attractant protein 1 (MCP1), 
interleukin 6 (IL6), and IL27 in peritoneal washings of mice immunized with А/PR8/NS124 were significantly higher compared 
to the mice immunized with the wild-type virus. The А/PR8/NS124 treated group showed a delayed attraction of monocytes and 
neutrophils as well as a more pronounced reduction in the percentage of dendritic cells in the peritoneal cavity. The expression 
level of the CD86 activation marker on the cells expressing the molecules of the major histocompatibility complex II (MHCII+) was 
significantly higher in mice immunized with А/PR8/NS124 than in the group immunized with А/PR8/full NS. Finally, immuniza-
tion with А/PR8/NS124 led to an increased formation of influenza-specific CD8+ effector T-cells characterized by the simultaneous 
production of IFNγ, IL2, and TNFα. We hypothesize that elevated cytokine production, enhanced dendritic cell migration, and in-
creased CD86 expression on antigen-presenting cells upon immunization with А/PR8/NS124 lead to a more effective presentation 
of viral antigens and, therefore, promote an increased antigen-specific CD8+ immune response. 
INTRODUCTION
Influenza viruses with shortened nonstructural NS1 pro-
teins have reduced reproductive activity in the respira-
tory tract of the host organism but can cause compre-
hensive humoral and cellular immune responses. That 
enables the development of live attenuated influenza 
vaccines based on this kind of viruses [1, 2]. The forma-
tion of virus-specific CD4+ and CD8+ T-lymphocytes in 
lungs and in lung draining lymph nodes as well as the 
significant antibody responses to the surface antigens 
of the influenza viruses with the modified NS genes has 
been shown in a number of studies: in mice [3, 4], horses 
[5], pigs [6, 7], poultry [1], ferrets [8], and macaques [9]. 
A live intranasal influenza vaccine, which was developed 
on the basis of the influenza virus with the removed NS1 
protein reading frame, has successfully passed clinical 
trials [2]. The modification of the NS gene by the intro-
duction of the foreign genome fragments from different 
pathogens is a promising approach for the creation of 
mucosal vector vaccines against various infections. In 
particular, immunization with a strain that contains NS1 
gene expressing Mycobacterium tuberculosis ESAT-6 pro-
tein results in the formation of a protective ESAT-6-spe-
cific Th1-type immune response [10].
Despite numerous studies conducted on the impact 
of the NS1 protein modifications on the formation of 
adaptive immunity to the influenza virus, the role of 
the cell-mediated innate immunity on the early stages 
of the immune response is still poorly understood. The 
cells of innate immunity serve as the first line of the 
body’s immune defense against viral infections. These 
cells are responsible for the activation of adaptive immu-
nity through the processing and presentation of antigens 
in the context of the major histocompatibility complex 
(MHC) as well as for the production of proinflammatory 
and regulatory cytokines, chemokines, and differentia-
tion factors [11, 12].
It is known that the full-length NS1 protein is directly 
involved in inhibiting the reactions of the innate immune 
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response against the influenza virus by suppressing the 
expression of genes of type I interferons (IFNs) and other 
proinflammatory factors [13]. In addition, the action of 
the NS1 protein has an impact on the effectiveness of the 
presentation of viral antigens by MHC molecules and, as 
a consequence, on the immunogenicity of influenza virus 
proteins [13, 14].
The goal of this study was to compare the cytokine 
production, kinetics of innate immune cell populations, 
expression of activation markers in antigen presenting 
cells (APC), and the levels of influenza-specific T-cellu-
lar response in mice immunized with virus containing 
NS1 protein shortened to 124 amino acid (a.a.) residues 
(А/PR8/NS124 or NS124) versus mice immunized with the 
virus with full length NS1 protein (А/PR8/full NS or full NS).
Taking into account the different reproductive activity 
of viruses with the truncated and intact NS1 proteins in 
the respiratory tract of animals, an intraperitoneal route 
of immunization was chosen in this study. This approach 
allowed for the compensation of the potential differenc-
es in antigenic load since the influenza virus is unable 
to reproduce in the peritoneal cavity [15]. The intraperi-
toneal immunization of mice with viruses containing 
full-length and modified NS1 proteins was described by 
B. Ferko et al. [4] when they used this approach to evalu-
ate the production of cytokines by different viruses. 
MATERIALS AND METHODS
Viruses
Two strains based on the influenza A/Puerto Rico/8/1934 
(H1N1) virus (A/PR8) encoding (1) the full-length NS1 
protein (A/PR8/full NS) and (2) shortened to 124 a.a. NS1 
protein (A/PR8/NS124) described earlier [3] were used in 
this study. The viruses were produced in developing chick 
embryos (CEs) and purified by high-speed centrifugation 
in a sucrose density gradient by the standard procedure.
Laboratory animals
The study was performed on C57BL/6 mice obtained from 
the Biomedical Science Center (Stolbovaya, Russia). All 
of the experiments in this research study were conducted 
according to the guidelines for care and work with labo-
ratory animals [16].
Determination of the virus infectious activity
The infectious activity of the virus strains was estimated 
by a limiting dilution assay performed in a chicken em-
bryo kidney (CEK) cells cultivated in DMEM-F12 medium 
(Gibco, USA) containing 6 mM GlutaMAX (Gibco, USA), 
1  mM sodium pyruvate CH3(CO)COONa (Gibco, USA), 
and 1% antibiotic-antimycotic solution for cell cultures 
(amphotericin B, penicillin, streptomycin; Gibco, USA). 
The assay was performed in 96-well culture plates (Nunc, 
Denmark) by the addition of 100 μl of prepared dilutions 
of the virus-containing material into the wells, and sub-
sequent incubation for 5 days at 34°C and 5% CO2. The 
results were evaluated visually by cytopathic effect esti-
mation, and a hemagglutination reaction (using a 0.5% 
suspension of chicken red blood cells) was used as the 
control. The calculation of virus 50% tissue culture in-
fectious dose (TCID50) was performed using the method 
described by Reed and Munch [17], and the viral titer was 
expressed as log10TCID50/ml.
In order to determine the dynamic of weight change, 
and the reproductive activity of the virus strains in the re-
spiratory tract of mice, animals were immunized intrana-
sally (i.n.) with 30 μl of a viral suspension (6.0 log10TCID50/
mouse) under light ether anesthesia. Lung collection was 
performed on the 2nd, 4th, and 6th days after infection. To-
ward this end, the mice were sacrificed by cervical dislo-
cation, after which the lungs were removed. The organs 
were homogenized using a Tissue Lyser II device (Qiagen, 
Germany) at 30 Hz for 6 min. The viral loads in the lungs 
of the immunized animals were estimated by the titra-
tion of tissue homogenates in the Madin-Darby Canine 
Kidney (MDCK) cells and expressed as log10TCID50/ml.
Immunization of the animals
The mice were immunized intraperitoneally with a sus-
pension of the corresponding virus in 500  μl of phos-
phate buffered saline (PBS, Biolot, Russia) solution 
(7.1  log10TCID50/mouse). The animals of the control 
group received the same volume of pure PBS.
Analysis of cytokine production in peritoneal 
washings
In order to collect peritoneal washings, the mice were 
sacrificed by cervical dislocation 12  h after immuniza-
tion and 1 ml of cold PBS was injected into the abdominal 
cavity using a syringe. After 5 min, the peritoneal wash-
ings were collected and transferred to test tubes. Samples 
were centrifuged for 10 min at 500 g (4°C) in an Eppen-
dorf 5810R centrifuge (A-4-81 rotor). The concentration 
of inflammatory cytokines in the supernatants was de-
termined using the LEGENDplex Mouse Inflammation 
Panel Kit in V-bottom plates (Biolegend, USA) according 
to the manufacturer’s instructions.
Flow cytometry
In order to analyze the dynamics of innate immunity cell 
populations, peritoneal washings were obtained 12 h and 
24 h after immunization. Cells (106 in 100 μl) were stained 
with fluorochrome-conjugated antibodies. Spleen ex-
traction and splenocyte isolation were performed at 8 
and 21  days post immunization (d.p.i.) to analyze the 
adaptive immune response. Cell stimulation was per-
formed in flat-bottomed 96-well plates (Nunc, Denmark) 
for 6 h with a mixture of the ASNENMETM peptide and 
brefeldin-A (BD Biosciences, USA). The ASNENMETM 
peptide corresponds to the highly immunogenic epitope 
of the influenza A/PR8 NP protein. Two panels of fluo-
rochrome-conjugated antibodies (BioLegend, USA) were 
used to identify the innate immunity cell populations 
and to analyze the activation marker expression levels: 1) 
CD11b-PE/Cy7, CD11c-PE, MHCII-Alexa488, CD103-Per-
CP-Cy5.5, CD45-APC/Cy7, CD64-BV421, CD24-BV510; 
and 2) CD45-APC/Cy7, MHCII-Alexa488, Ly6G-PerCP-
Cy5.5, CD86-BV421, and CD83-BV510. Identification 
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of the adaptive immunity cells was performed using 
the fluorochrome-conjugated antibody set containing 
CD4-PerCP-Cy5.5, CD8-PE/Cy7, CD62L-APC/Cy7, and 
CD44-BV421 (BioLegend, USA). Intracellular produc-
tion of cytokines was assessed using antibodies against 
IFNγ-FITC, IL2-PE, and TNFα-BV510 (BioLegend, USA). 
Staining for the detection of intracellular markers was 
performed using the Fixation and Permeabilization Solu-
tion reagent kit (BD Biosciences, USA) according to the 
manufacturer’s instructions. Zombie Red viability mark-
er (BioLegend, USA) was used to identify the dead cells. 
True Stain reagent, containing antibodies to CD16/CD32, 
was used to block non-specific antibody binding (BioLe-
gend, USA). Data were collected on a BD FACSCanto II 
flow cytometer (BD Biosciences, USA). The results were 
analyzed using the Kaluza Analysis 1.5a program (Beck-
man Coulter, USA).
Statistical analysis 
Statistical processing of the results was carried out using 
the RStudio Desktop 1.0.153 program (RStudio Inc, USA). 
The experimental and control groups were compared 
using the Dunnett’s test. The comparison of the experi-
mental groups was carried out using the Student’s t-test.
RESULTS
Pathogenicity of virus strains in mice and their 
reproductive activity in the respiratory tract of 
animals
The effect of shortening of the NS1 protein on the patho-
genicity and reproductive activity of the influenza vi-
rus was evaluated by a comparison of the changes in 
the body weight of mice immunized with A/PR8/NS124 
and A/PR8/full  NS viruses. The single immunization of 
the animals with the virus A/PR8/NS124 containing the 
shortened NS1 protein did not lead to a decrease in body 
weight (Fig.  1). However, the immunization of animals 
with an equivalent dose of the pathogenic A/PR8/full NS 
virus led to a drop in the total body weight of the group 
to 85% of original weight by the 6th day after infection. 
Fig. 1. The dynamic of weight change of the mice immunized 
with А/PR8/full NS and А/PR8/NS124 viruses. The data are pre-
sented as a mean of the percentage of the body weight change from 
the initial weight value (Mean±SEM). Each experimental group in-
cluded 10 mice (n=10). The number of mice in the control group: 
n=6.
In order to determine the reproductive activity of the 
virus strains, viral loads in the lungs of immunized ani-
mals were estimated by the titration of tissue homoge-
nates in the MDCK cells. The results are shown in Table 1.
Table 1. Replication rate of the А/PR8/NS124 and А/PR8/full NS 
viruses in the lungs of mice after the intranasal immunization 
Virus strain Viral titer in the lungs of mice
(log10TCID50/ml)
2nd day 4th day 6th day
А/PR8/NS124 3.70 ± 0.71*** 3.80 ± 1.20*** 4.40 ± 1.85
А/PR8/full NS 6.80 ± 0.71 7.00 ± 0.54 6.50 ± 0.67
Two groups of mice were immunized i.n. with А/PR8/full  NS and 
А/PR8/NS124 viruses (6.0  log10TCID50/mouse). On the 2
nd, 4th, and 6th 
days, 5 animals from each group were sacrificed and the viral titers in 
the lungs were determined. The data are presented as Mean ± SD. 
*** indicates the significant difference (p<0.001, Student’s t-test) be-
tween the groups.
The obtained results show that the shortening of the 
NS1 protein leads to the attenuation of the virus, which 
is proved by the lower reproduction rate of the virus in 
lungs and by the absence of the body weight loss of the 
immunized animals. Statistically significant differenc-
es in viral titers were observed on the 2nd and 4th d.p.i. 
(p=0.0008 and p=0.003, respectively), whereas on the 6th 
day the difference between the groups was not signifi-
cant (p=0.08).
Increased cytokine induction by A/PR8/NS124 
versus A/PR8/full NS strain
Considering the differences found in reproductive activ-
ity between the A/PR8/full NS and A/PR8/NS124 strains 
in the respiratory tract of mice, an intraperitoneal route 
of immunization was chosen in order to compare the im-
munogenicity of these viruses.
The analysis of the concentration of inflammatory 
cytokines in peritoneal washings of mice showed that 
immunization with the A/PR8/NS124 strain leads to an 
increased induction of cytokines compared to the virus 
with the full-length NS1 protein (Fig. 2). The most pro-
nounced difference was observed for IFNβ: the produc-
tion of this cytokine by mice in the NS124 group was 
almost 300 times higher than by animals in the full NS 
group (65635.7±14650.3  pg/ml and 223.6±140.3  pg/
ml, respectively). In addition, a significant difference 
was detected in the IL27 levels: the concentration of 
this cytokine in the peritoneal washings of mice immu-
nized with the virus containing truncated NS1 protein 
was fourfold higher than that in the group immunized 
with the full-length NS1 protein (508.6±193.5 pg/ml and 
125.2±64.6  pg/ml, respectively). The levels of IL6 and 
MCP1 production increased in both groups following 
the immunization. At the same time, in the animals im-
munized with the A/PR8/NS124 virus, these levels were 
on average 1.8 (IL6) and 2.0 (MCP1) times higher than 
in mice that received the A/PR8/full NS strain. The same 
pattern was observed for the TNFα, IL2p70, and IL1β cy-
tokine concentrations which were 1.5-2.0 times higher in 
the A/PR8/NS124 virus group versus the A/PR8/full  NS 
group. The increased production of the GM-CSF and IFNγ 
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cytokines was observed in both groups when compared 
to the control group. However, the differences between 
A/PR8/full NS and A/PR8/NS124 groups in the produc-
tion of these cytokines were not significant in both 
cases (p=0.09). 
The main innate immunity cell populations 
in peritoneal washings of mice
A panel of markers (CD45, MHCII, CD11c, CD11b, CD24, 
CD64, and Ly6G) has been used for the identification of 
the main populations of innate immunity cells in the 
lungs [18, 19] and other organs (small intestine, heart, 
kidney, liver, peripheral organs of the immune system) of 
mice [19]. We used this approach to analyze the cellular 
composition of peritoneal washings in mice. We have de-
veloped a panel of fluorochrome-conjugated antibodies 
that enable the differentiation of macrophages (CD45+ 
MHCII+ CD64+ CD11c/CD11b+), dendritic cells (DCs) 
(CD45+ MHCII+ CD64- CD24+ CD11c/CD11b+), monocytes 
(CD45+ MHCII- CD64+ CD11c/CD11b+), and neutrophils 
(SSChi CD45+ Ly6G+) (Fig. 3). Individual subpopulations of 
DCs were identified by the expression level of markers 
CD11b and CD103.
Influx dynamics of monocytes and neutrophils 
in the peritoneal cavity
The relative content of the main populations of innate 
immunity cells at different time points after the immu-
nization is shown in Fig. 4. Twelve hours after the admin-
istration of the A/PR8/full NS, a significant increase was 
detected in the relative number of monocytes and neu-
trophils compared with the control group: 2.74±2.48% 
(0.14±0.10% in control group) and 17.65±11.32% 
(0.93±0.24% in control group), respectively. In the A/PR8/
NS124 immunized group, however, no significant chang-
es in the relative number of these cells were detected. 
The relative number of macrophages at the same time 
point after the immunization has significantly changed 
in both the full NS (p=0.01) and NS124 groups (p=0.05) 
versus the control group. At 24  h post immunization, 
Fig. 2. Concentration of cytokines in the peritoneal washings of mice immunized with А/PR8/full NS and А/PR8/NS124 viruses. 
The results are presented as individual values. The horizontal lines indicate the mean values for each group, (n=10). The (*) symbol indi-
cates a significant difference between the full NS and NS124 groups (*: р<0.05, **: p<0.01, ***: p<0.001, Student’s t-test).
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Fig. 3. The gating strategy for the identification of key cell populations in mouse peritoneal washings. After the elimination of cell 
doublets and clumps (by FSC-A/FSC-H, not shown) and isolation of the live, single cell population (based on the FSC-A/SSC-A light scat-
tering and binding of the Zombie Red dye), the immunocytes were gated according to the presence of the CD45 marker. 
Legend: LC – living cells; Leuk. – leukocytes; APC – antigen-presenting cells (CD45+ CD11c/CD11b+ MHCII+); Mon. – monocytes (CD45+ 
CD11c/CD11b+ MHCII- CD64+ CD24); Gran. – granulocytes (neutrophils and eosinophils, CD45+ CD11c/CD11b+ MHCII- CD64- CD24+); 
Neut. – neutrophils (SSChi CD45+ Ly6G+); DC1 – CD11b- DCs (CD45+ CD11c+ CD11b- MHCII+ CD64- CD24+); DC2 – CD11bint DCs (CD45+ 
CD11c+/-CD11bint MHCII+ CD64- CD24+); DC3 – CD11bhi DCs (CD45+ CD11c+/-CD11bhi MHCII+ CD64- CD24+); DC4 – CD103+ DCs (CD45+ 
CD11c/CD11b+ CD103+ MHCII+ CD64- CD24+).
a significantly higher relative content of monocytes, 
macrophages, and neutrophils was detected in both the 
NS124 and the full  NS groups. It should be mentioned 
that the relative number of the neutrophils at 12  h for 
the NS124 group was significantly lower than that of the 
full  NS group, whereas at 24  h this tendency remained 
but the difference was not significant.
Relative composition of dendritic cell populations 
in the peritoneal cavity
In this study, DCs were identified as follows. After the 
initial gating to retain CD45+CD11c/CD11b+MHCII+CD64-
CD24+ cells, CD11b and CD103 markers were used to fur-
ther identify 4  DC populations (Fig.  3). The DCs, char-
acterized by an intermediate level of CD11b expression 
(CD11bint DC), made up the largest fraction of DCs in the 
peritoneal cavity.
Twelve hours after the administration of virus there 
was a significant reduction in the fraction of CD11bint 
DCs in the full NS group compared with the control group 
(p=0.0009) (Fig.  5), while no significant changes were 
detected in the NS124 group. After 24  h, both groups 
showed a significant decrease in the CD11bint DCs per-
centage (p=0.00002, p=0.00003), although in the NS124 
group the changes were less pronounced.
The viral administration caused a different response 
in the minor DC populations, including CD11bhi DCs, 
CD11b- DCs, and CD103+ DCs. An increase in the relative 
content of these populations occurred 12 h after immu-
nization. In the case of CD11bhi DCs and CD103+ DCs, the 
differences versus the control group were statistically 
significant (full NS: p=0.0001, p=0.0007; NS124: p=0.01, 
p=0.007, respectively). At 24  h post immunization, the 
percentage of all DC populations in the NS124 group had 
decreased versus the total number of CD45+ abdominal 
cells. At the same time, in the full NS group the relative 
content of CD11bhi DCs remained at a higher level than 
in the control group and the percentage of CD103+ DCs 
decreased back to the control group level, while in the 
NS124 group the CD103+ DC population percentage was 
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Fig. 4. The relative composition of the predominant innate immune cell populations. The dots represent the proportions of the 
corresponding cell populations in individual animals versus the total number of living CD45+ cells. The mean values for the groups (n=5) 
are shown by a horizontal line. The (*) symbol indicates the significant differences versus the control group (*: p<0.05, **: p<0.01, ***: 
p<0.001, Dunnett’s test). The (♦) symbol indicates significant differences between the two experimental groups: full NS and NS124 (♦: 
p<0.05, Student’s t-test).
Fig. 5. The relative composition of different DC populations. The dots represent the percentage of the corresponding cell popula-
tions in individual animals versus the total number of living CD45+ cells. The mean values for the groups (n=5) are shown by a horizontal 
line. The (*) symbol indicates the presence of significant differences versus the corresponding values for the control group (*: p<0.05, **: 
p<0.01, ***: p<0.001, Dunnett’s test). The (♦) symbol indicates significant differences between the two experimental groups: full NS and 
NS124 (♦: p<0.05, ♦♦: p<0.01, Student’s t-test).
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significantly lower than in the control group. Thus, 24 h 
after the immunization with the A/PR8/NS124 strain, 
a statistically significant decrease in the relative content 
of CD11bhi DCs and CD103+ DCs was observed (p=0.004 
and p=0.02, respectively).
Enhancement of the costimulatory factor CD86 
expression
The results of analysis of CD45+ MHCII+ APCs by median 
fluorescent intensity (MFI) of CD83 and CD86 (APC acti-
vation markers), at 12 h and 24 h after immunization, are 
presented in Fig. 6. It was found that the level of CD83 
expression increased in response to the virus administra-
tion in both the full NS and the NS124 groups: the sta-
tistically significant differences versus the control group 
(p=0.01, p=0.03) were observed starting from 12  h and 
lasting up to 24 h after the immunization. 
The expression level of CD86 increased considerably 
12  h after virus administration. Significant differences 
versus the control group were observed in both groups 
of the immunized animals, and the MFIs obtained at this 
time point had similar values for the full NS and NS124 
groups. At 24 h post-immunization, the expression level 
of CD86 in the NS124 group had increased even more, re-
vealing statistically significant differences not only with 
the control group (p=0.00003), but also with the full NS 
group (p=0.006).
Adaptive T-cell immune response
At the final stage of the study, the adaptive T-cell im-
mune responses to the immunodominant epitope of the 
NP protein were evaluated. It was found that the percent-
age of antigen-specific CD8+ T-cells in the spleen of mice 
from the NS124 group was significantly higher than that 
of the control group and approx. 1.5-2.0 times higher 
than in the full NS group on the 8th and 21st day after im-
munization (Fig. 7). At the same time, the biggest differ-
ences were due to the changes of the polyfunctional CD8+ 
T-lymphocytes fractions that were simultaneously ex-
pressing IFNγ, IL2, and TNFα cytokines. After 8 days, the 
results were: full NS 5.9±0.5, NS124 10.7±1.6, p=0.0008; 
after 21 days: full NS 4.9±0.5, NS124 7.3±0.4, p=0.0003. 
In addition, on the 8th day after immunization, a high-
er content of CD8+ T-lymphocyte subpopulations (with 
the phenotypes IFNγ+ IL2+ TNFα-, and IFNγ+  IL2-  TNFα+) 
was observed in the NS124 group (1.5±0.5 and 8.9±2.6, 
p=0.05) versus the full NS group (0.5±0.08 and 5.6±1.04, 
p=0.008). On the 21st day after the immunization, the 
composition of cytokine-producing cell populations in 
the NS124 group had changed resulting in an increase of 
the percentage of IFNγ+ IL2+ TNFα+ and IFNγ+ IL2- TNFα+ 
T-lymphocytes and a decrease in the relative content of 
IFNγ+ IL2- TNFα- cells (Fig. 7).
DISCUSSION
In the present study, we compared the innate and adap-
tive T-cell immune responses to influenza A viruses with 
the full-length NS1 protein and with the NS1 protein 
shortened to 124 a.a. The comparison of the inflamma-
tory cytokine production in the cells from the peritone-
al washings of mice immunized with A/PR8/full NS and 
A/PR8/NS124 strains showed that shortening of the NS1 
protein leads to a decrease of the immunosuppressive 
activity of the influenza virus. This effect was accompa-
nied by a significant increase in the production of IFNβ, 
IL6, TNFα, IL12p70, IL27, MCP1, and IL1β in response 
to immunization with the A/PR8/NS124 strain. The ob-
tained experimental data on the increased production 
of the IL12 cytokine family members (IL12p70, IL27) is 
an important contribution to the known information on 
the high cytokine inducing potential of influenza viruses 
with the truncated NS1 proteins [4, 20]. The most pro-
nounced difference between A/PR8/full  NS and A/PR8/
NS124 viruses was associated with IFNβ production, 
which is suppressed by the interaction of the NS1 protein 
with the intracellular pattern-recognition receptor RIG-I 
and other components of type I IFN signaling pathway 
[21, 22]. Since the production of IFNα/β begins at the ear-
liest stages of the innate antiviral immune response and 
involves the activation of the expression of a variety of 
Fig. 6. The expression level of CD83 and CD86 molecules on the APCs from the peritoneal cavity of mice. The MFI of the CD83 and 
CD86 markers for each animal is shown. The mean values for the groups (n=5) are shown by a horizontal line. The (*) symbol indicates the 
presence of significant differences versus the corresponding values for the control group (*: p<0.05, **: p<0.01, ***: p<0.001, Dunnett’s 
test). The (♦) symbol indicates significant differences between the two experimental groups: full NS and NS124 (♦: p<0.05, Student’s 
t -test).
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IFN-stimulated genes (ISGs), the increased production of 
proinflammatory cytokines after immunization with the 
A/PR8/NS124 virus as observed in our experiments can 
be probably explained by the high ability of this strain to 
induce IFN.
Our experiments showed that the intraperitoneal ad-
ministration of viruses causes the active migration of 
monocytes, macrophages, and neutrophils into the ab-
dominal cavity. According to the literature data, these 
cells are involved in the early stage of immune protection 
against influenza [23]. The resident macrophages accom-
plish the phagocytosis of infected host cells thereby lim-
iting the spread of the virus [24]. In addition, they attract 
monocytes that are differentiating into macrophages and 
monocytic dendritic cells to the nidus of inflammation 
[25]. Neutrophils also take an active part in the phagocy-
tosis of viral particles and apoptotic cells at the nidus of 
infection [26]. In addition, they have an important role 
in attracting cytotoxic T-lymphocytes: according to Lim 
et al. [27], moving neutrophils leave behind a chemokine 
trace containing predominantly CXCL12, which directs 
the migration of T-cells. It is well known that neutrophils 
perform the MHCI-dependent presentation of viral an-
tigens in mice and also express the CD80 and CD86 co-
stimulatory molecules [28].
Despite the increased induction of cytokines by the 
A/PR8/NS124 strain, the portion of monocytes, macro-
phages, and neutrophils in peritoneal washings of mice 
initially increased faster in response to immunization 
with the A/PR8/full NS strain. However, by the 21st day 
after immunization, these parameters had leveled off. It 
is known that type I IFNs can have both activating and 
inhibitory effects on the cells of the immune system de-
pending on their concentration and the duration of in-
teraction [29]. In addition to proinflammatory factors, 
such as the ones measured in the present study, IFNα/β 
induce the production of a number of anti-inflamma-
tory cytokines as well as the expression of some genes 
responsible for the induction of apoptosis. It is possible 
that the hyperproduction of IFNβ, observed after the im-
munization of mice with A/PR8/NS124 virus, suppressed 
the migration of neutrophils and monocytes to the peri-
toneal cavity.
We analyzed the dynamics of the relative composition 
of the different subpopulations of dendritic cells. These 
immunocytes are heterogeneous in their composition, 
origin, location, and function. According to the literature 
data, over the course of the immune response develop-
ment, CD11b+ and CD103+ DCs migrate to the secondary 
organs of the immune system. Experiments that used a 
recombinant A/PR8 virus containing a green fluorescent 
protein (GFP) imbedded in the full-length NS1 protein 
showed that 8.5% of the CD103+ conventional DCs (cDC) 
of the mediastinal lymph nodes are GFP positive after 
48 h post immunization, while among CD11b+ cDCs, only 
0.5% of cells contained a fluorescent protein. This may 
be the evidence of a more intensive migration of CD103+ 
cDCs to the lymph nodes, although it may also indicate 
differences in the permissibility of different DC popula-
tions for the influenza virus [30].
We used a panel of fluorochrome-conjugated anti-
bodies for the identification of the four subpopulations 
Fig.  7. Production of cytokines IFNγ, IL2, and TNFα by CD8+ T-lymphocytes of mice immunized with A/PR8/full  NS and A/
PR8/NS124 viruses. The percentage of the total cytokine-producing T-lymphocytes from the total number of effector CD8+ T-cells 
(CD8+ CD44+ CD62L-) for the immunized and control groups are presented. The mean values for each group (n=4) are shown by a horizon-
tal line. The relative compositions of populations producing 1, 2, or 3 cytokines simultaneously are shown in the pie charts. The (*) symbol 
indicates significant differences between the two experimental groups: full NS and NS124 (*: p<0.05, **: p<0.01, Student’s t-test).
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of dendritic cells based on the expression of CD11b and 
CD103 markers in our experiments. The analysis of the 
dynamics in the relative content of CD11bhi DC, CD11b- 
DC, and CD103+ DC populations leads to the suggestion 
that 24 h after the immunization the DCs leave the viral 
entry zone. At the same time, a more pronounced de-
crease in the content of DCs was observed in the NS124 
group. That could be an indication of the enhanced mi-
gration of DCs to the peripheral lymph nodes for the pre-
sentation of the antigen to naïve T-lymphocytes [31, 32].
The analysis of the CD83 and CD86 expression is 
widely used to study the activation of cells of innate and 
acquired immunity. It is well known that an increase in 
the expression of these markers is associated with the 
APC maturation and the presentation of antigens [33, 
34]. We have shown that the level of CD86 expression in 
mice immunized with the A/PR8/NS124 strain was sig-
nificantly higher than that in the A/PR8/full NS group at 
24 h after the immunization. It is possible that this ef-
fect is due to a lack of immunosuppressive activity of the 
truncated protein NS1, thereby allowing the APCs of ani-
mals, immunized with the A/PR8/NS124 virus, to main-
tain CD86 expression at a high level. On the contrary, in 
the mice immunized with the strain A/PR8/full NS, the 
concentration of these markers is reduced at 24  h post 
immunization.
The ability of the influenza virus containing the trun-
cated NS1 protein to stimulate the higher cytokine pro-
duction as well as CD86 expression suggests that immuni-
zation with A/PR8/NS124 can lead to a more pronounced 
adaptive CD8+ T-cell immune response to influenza an-
tigens. Our experimental results showed that immuniza-
tion with A/PR8/NS124 strain induces the formation of 
a greater number of virus-specific CD8+ T-lymphocytes. 
The predominant cells among these lymphocytes are the 
multifunctional CD8+ effector cells (FNγ+IL2+TNFα+ and 
IFNγ+IL2-TNFα+), which are known for their important 
role in the formation of the protective antiviral immune 
response [35].
Thus, based on the obtained data, we conclude that 
shortening of the NS1 protein leads to an increase in 
the influenza virus immunogenicity. It contributes to a 
more effective presentation of viral antigens due to the 
intensification of dendritic cell migration as well as due 
to the increase in the CD86 costimulatory factor expres-
sion. That, in turn, leads to the formation of a more pro-
nounced adaptive T-cell immune response, accompanied 
by the formation of polyfunctional effector T-lympho-
cytes. The results of this study are the theoretical justifi-
cation for the use of viruses with truncated NS1 protein 
as live attenuated influenza vaccines and vectors.
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